# Santosh M. Nair, MD – FDA Inspection, Feb 26, 2020

Source: https://www.keypedia.com/records/fda_inspections/santosh-m-nair-md/58de3cd9-7259-4047-b641-e8b9ed1f7d7f
Source feed: FDA_Inspections

> FDA inspection 1120127 of Santosh M. Nair, MD, February 26, 2020. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 312. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1120127
- Company Name: Santosh M. Nair, MD
- Inspection Date: 2020-02-26
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Documents

- FDA Inspection 1218710 - 2023-09-21

Company: https://www.keypedia.com/companies/santosh-m-nair-md/bbab908a-9a0b-4728-b428-8757deef7358

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
